We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$296M
Cap. Flow
+$131M
Cap. Flow %
4.52%
Top 10 Hldgs %
24.94%
Holding
240
New
84
Increased
29
Reduced
44
Closed
78

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$90.9M
2
FDX icon
FedEx
FDX
+$83M
3
HUB.B
HUBBELL INC CL-B
HUB.B
+$78.8M
4
BAX icon
Baxter International
BAX
+$75.4M
5
PPG icon
PPG Industries
PPG
+$64.5M

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$54.1M
2
HUN icon
Huntsman Corp
HUN
+$52.6M
3
AGN
Allergan Inc
AGN
+$50.5M
4
GILD icon
Gilead Sciences
GILD
+$48.4M
5
GRMN
Garmin
GRMN
+$39.9M

Sector Composition

Rank Sector Weight
1 Technology 19.08%
2 Healthcare 14.39%
3 Consumer Discretionary 11.4%
4 Industrials 10.61%
5 Financials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIS icon
126
Fidelity National Information Services
FIS
$21.5B
$2.59M 0.09%
+38,110
New +$2.49M
LH icon
127
Labcorp
LH
$24.3B
$2.52M 0.09%
23,280
-172,107
-88% -$17.7M
EIGR
128
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.46M 0.08%
+289
New +$2.53M
CBT icon
129
Cabot Corp
CBT
$4.65B
$2.46M 0.08%
+54,652
New +$2.41M
TGI
130
DELISTED
Triumph Group
TGI
$2.39M 0.08%
+40,000
New +$2.4M
LGF
131
DELISTED
Lions Gate Entertainment
LGF
$2.1M 0.07%
+62,031
New +$1.95M
ETN icon
132
Eaton
ETN
$157B
$2.1M 0.07%
+30,858
New +$2.1M
CARM
133
DELISTED
Carisma Therapeutics
CARM
$1.87M 0.06%
+10,500
New +$2.29M
STRZA
134
DELISTED
Starz - Series A
STRZA
$1.72M 0.06%
50,000
-213,329
-81% -$6.69M
RRTS
135
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$1.7M 0.06%
+2,693
New +$1.62M
JRVR icon
136
James River Group Holdings
JRVR
$218M
$1.67M 0.06%
+71,029
New +$1.59M
ESI icon
137
Element Solutions
ESI
$9.12B
$1.65M 0.06%
64,173
+254
+0.4% +$6.11K
PSX icon
138
Phillips 66
PSX
$82.9B
$1.57M 0.05%
20,000
-80,782
-80% -$5.93M
VNDA icon
139
Vanda Pharmaceuticals
VNDA
$312M
$1.57M 0.05%
+168,300
New +$1.9M
SUM
140
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.27M 0.04%
+60,537
New +$1.23M
AAL icon
141
American Airlines Group
AAL
$9.58B
$1.24M 0.04%
23,522
-102,430
-81% -$5.2M
VIRX
142
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.23M 0.04%
+2,381
New +$1.2M
CSIQ icon
143
Canadian Solar
CSIQ
$906M
$1.17M 0.04%
+35,000
New +$966K
FOMX
144
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.15M 0.04%
+124,551
New +$1.11M
ELDN icon
145
Eledon Pharmaceuticals
ELDN
$276M
$1.13M 0.04%
+617
New +$1.36M
TDG icon
146
TransDigm Group
TDG
$69.2B
$1.1M 0.04%
5,043
+20
+0.4% +$4.21K
B
147
Barrick Mining
B
$62.2B
$1.09M 0.04%
+100,000
New +$1.18M
EUFN icon
148
iShares MSCI Europe Financials ETF
EUFN
$3.87B
$905K 0.03%
39,400
-43,600
-53% -$970K
LOXO
149
DELISTED
Loxo Oncology, Inc
LOXO
$871K 0.03%
+70,000
New +$872K
ADVM
150
DELISTED
Adverum Biotechnologies
ADVM
$811K 0.03%
+2,000
New +$845K
4 5
6
7 8

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Ascend Capital held 240 positions worth $2.9B, up 11% from $2.61B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ascend Capital deployed $131M of net new capital in Q1 2015, opening 84 new positions and adding to 29 existing holdings. Its largest new stake was Danaher: 1,583,604 shares worth $90.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Huntsman Corp, an estimated $52.6M trimmed.

  • Ascend Capital's largest Q1 2015 buy was Danaher: 1,583,604 shares worth $90.4M.
  • Ascend Capital added most to PPG Industries in Q1 2015, an estimated $64.5M increase.
  • Ascend Capital's biggest Q1 2015 reduction was Huntsman Corp, cutting an estimated $52.6M.
  • Ascend Capital fully exited Andeavor in Q1 2015, selling an estimated $54.1M.
  • Ascend Capital's ten largest holdings make up 25% of its $2.9B portfolio in Q1 2015.
  • Ascend Capital opened 84 new positions and closed 78 in Q1 2015.
  • Ascend Capital's portfolio value rose 11% quarter-over-quarter to $2.9B.

Based on Ascend Capital's 13F filing for Q1 2015, filed 14 May 2015.